Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS · Delayed Price · Currency is USD
0.0148
-0.0077 (-34.22%)
At close: Nov 6, 2026
Rafarma Pharmaceuticals Revenue
In the fiscal year ending March 31, 2012, Rafarma Pharmaceuticals had annual revenue of $133.33K. That makes Rafarma Pharmaceuticals the 45,864th largest company in the world by revenue and 6,730th in the United States.
Revenue
133.33K
Revenue Growth
n/a
P/S Ratio
9.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2012 | 133.33K | - | - |
| Mar 31, 2011 | 133.33K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Rafarma Pharmaceuticals News
- 1 year ago - Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th - GlobeNewsWire
- 2 years ago - Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea - GlobeNewsWire
- 2 years ago - Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care - GlobeNewsWire
- 2 years ago - Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University - GlobeNewsWire
- 2 years ago - Rafarma Pharmaceutical news update - GlobeNewsWire
- 4 years ago - Rafarma Pharmaceuticals strengthens its position in Central Asia - GlobeNewsWire
- 4 years ago - Rafarma's Slavich Noya Technology Division Expands Printing Production - GlobeNewsWire
- 4 years ago - RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research - GlobeNewsWire